Recurrent dermatitis and dermal hypersensitivity following a jellyfish sting: a case report and review of literature.
Jellyfish envenomation often causes an immediate painful vesiculopapular eruption. Less commonly it can cause a type IV allergic hypersensitivity that manifests with delayed or recurrent cutaneous lesions at the primary site or distant from the primary site. These secondary reactivations may be related to high antijellyfish immunoglobulin levels, intracutaneously sequestered antigen, or cross-reacting venom. Immunomodulators such as pimecrolimus and tacrolimus and topical and intralesional corticosteroid therapy decrease this recurrent dermatitis. We report a case of a 9-year-old girl with a recurrent jellyfish dermatitis lasting more than 1 year after the initial envenomation. The dermatitis finally resolved after treatment with tacrolimus and intralesional triamcinolone acetonide therapy.
Department of Pediatrics, St. Christopher's Hospital, Philadelphia, Pennsylvania.
Manuela
M
Loredana Asztalos
Adam I
AI
Rubin
Rosalie
R
Elenitsas
Caroline
C
Groft MacFarlane
Leslie
L
Castelo-Soccio
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001733:Bites and Stings / Q000188:drug therapy / Q000276:immunology*; D002648:Child; D003064:Cnidarian Venoms / Q000506:poisoning*; D003872:Dermatitis / Q000188:drug therapy / Q000209:etiology / Q000276:immunology*; D005260:Female; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000188:drug therapy / Q000209:etiology / Q000276:immunology*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015552:Injections, Intralesional; D007868:Leg Dermatoses / Q000188:drug therapy / Q000209:etiology / Q000276:immunology*; D012008:Recurrence; D016559:Tacrolimus / Q000627:therapeutic use; D014221:Triamcinolone / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D003064:Cnidarian Venoms; D007166:Immunosuppressive Agents; D014221:Triamcinolone; D016559:Tacrolimus